Cita APA

Capdevila, J., Hernando, J., Teule, A., Lopez, C., Garcia-Carbonero, R., Benavent, M., . . . García-Carbonero, R. (2023). Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin.

Citación estilo Chicago

Capdevila, J., et al. Durvalumab Plus Tremelimumab for the Treatment of Advanced Neuroendocrine Neoplasms of Gastroenteropancreatic and Lung Origin. 2023.

Cita MLA

Capdevila, J., et al. Durvalumab Plus Tremelimumab for the Treatment of Advanced Neuroendocrine Neoplasms of Gastroenteropancreatic and Lung Origin. 2023.